Abstract
Baicalein is a 5,6,7-trihydroxy flavone that exhibits many pharmacological activities and is used in the treatment of many conditions such as inflammations, cancers, hepatic problems, diabetes, viral infections, ulcerative colitis, thrombosis, and neurological disorders. This chapter is designed to cover the research advances on resources, biosynthesis pathway and biotransformation, absorption, metabolism, excretion, molecular mechanism, and pharmacological action that have been performed on the baicalin activity.
References
Abu B, Zandi K, Jefreee J (2013) Antiviral activity of baicalein against Japanese encephalitis virus – Patent WO-2014142644-A1 – PubChem
Barich DH, Zell MT, Munson EJ (2016) Physicochemical properties, formulation, and drug delivery. Drug Deliv Princ Appl Second Ed 35–48. https://doi.org/10.1002/9781118833322.ch3
Bhandari M, Bhandari A, Prakash R, Bhandari A (2010) Scutellaria baicalensis Georgi: A rising paradigm of herbal remedies. WebmedCentral Pharm Sci 1:WMC001105. https://doi.org/10.9754/journal.wmc.2010.001105
Chen LJ, Games DE, Jones J (2003) Isolation and identification of four flavonoid constituents from the seeds of Oroxylum indicum by high-speed counter-current chromatography. J Chromatogr A 988:95–105. https://doi.org/10.1016/S0021-9673(02)01954-4
Chen Z, Hou R, Gao S et al (2018) Baicalein inhibits proliferation activity of human colorectal cancer cells HCT116 through downregulation of Ezrin. Cell Physiol Biochem 49:2035–2046. https://doi.org/10.1159/000493714
Choi EO, Jeong JW, Park C et al (2016) Baicalein protects C6 glial cells against hydrogen peroxide-induced oxidative stress and apoptosis through regulation of the Nrf2 signaling pathway. Int J Mol Med 37:798–806. https://doi.org/10.3892/IJMM.2016.2460/HTML
Dinda B, Silsarma I, Dinda M, Rudrapaul P (2015) Oroxylum indicum (L.) Kurz, an important Asian traditional medicine: From traditional uses to scientific data for its commercial exploitation. J Ethnopharmacol 161:255–278. https://doi.org/10.1016/j.jep.2014.12.027
Dong R, Li L, Gao H et al (2021) Safety, tolerability, pharmacokinetics, and food effect of baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled, single-dose phase I study. J Ethnopharmacol 274:114052. https://doi.org/10.1016/j.jep.2021.114052
Du G, Cheng Y, Mu X, et al (2012) Use of baicalein in manufacturing medicament for preventing and treating Parkinson’s disease – Patent WO-2012040919-A1 – PubChem
Du G, Lv Y, Wang K, et al (2020) Application of baicalein in preparing drug for preventing and/or treating novel coronavirus infectious disease – Patent WO-2021159570-A1 – PubChem
Fang P, Yu M, Shi M et al (2020) Baicalin and its aglycone: a novel approach for treatment of metabolic disorders. Pharmacol Reports 72:13–23. https://doi.org/10.1007/s43440-019-00024-x
Feng P, Yang Y, Liu N, Wang S (2022) Baicalin regulates TLR4/IκBα/NFκB signaling pathway to alleviate inflammation in Doxorubicin related cardiotoxicity. Biochem Biophys Res Commun 637:1–8. https://doi.org/10.1016/j.bbrc.2022.10.061
Froldi G, Ragazzi E (2022) Selected plant-derived polyphenols as potential therapeutic agents for peripheral artery disease: Molecular mechanisms, efficacy and safety. Molecules 27. https://doi.org/10.3390/molecules27207110
Fu Z, Di Y, Gao L et al (2015) The drug metabolism and pharmacokinetics investigation about baicalin effect and baicalein on mice U14 cervical cancer. J Spectrosc 2015:1. https://doi.org/10.1155/2015/632062
Gao D, Tawa R, Masaki H et al (1998) Protective effects of baicalein against cell damage by reactive oxygen species. Chem Pharm Bull 46:1383–1387. https://doi.org/10.1248/cpb.46.1383
Groschup M, Eiden M (2008) Flavonoid as means for the prophylaxis and treatment of neurodegenerative and other protein folding-aberration diseases – Patent WO-2009083612-A3 – PubChem
Gu L, Xu F, Zhang X, Gu Z (2022) Baicalein inhibits the SMYD2/RPS7 signaling pathway to inhibit the occurrence and metastasis of lung cancer. J Oncol 2022:1. https://doi.org/10.1155/2022/3796218
Ikezoe T, Chen SS, Heber D et al (2001) Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest. Prostate 49:285–292. https://doi.org/10.1002/pros.10024
Jin H, Wang Q, Wu J et al (2019) Baicalein inhibits the IL-1β-induced inflammatory response in nucleus pulposus cells and attenuates disc degeneration in vivo. Inflammation 42:1032–1044. https://doi.org/10.1007/s10753-019-00965-8
Kang KA, Zhang R, Piao MJ et al (2012) Baicalein inhibits oxidative stress-induced cellular damage via antioxidant effects. Toxicol Ind Health 28:412–421. https://doi.org/10.1177/0748233711413799
Keshari AK, Kumar G, Kushwaha PS et al (2016) Isolated flavonoids from Ficus racemosa stem bark possess antidiabetic, hypolipidemic and protective effects in albino Wistar rats. J Ethnopharmacol 181:252–262. https://doi.org/10.1016/j.jep.2016.02.004
Kim DH, Hossain MA, Kang YJ et al (2013) Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice. Int J Oncol 43:1652–1658. https://doi.org/10.3892/ijo.2013.2086
Kim YJ, Kim HJ, Lee JY et al (2018) Anti-inflammatory effect of baicalein on polyinosinic–polycytidylic acid-induced RAW 264.7 mouse macrophages. Viruses 10. https://doi.org/10.3390/v10050224
Kim G, Han D-W, Lee JH et al (2023) The cytoprotective effects of baicalein on H2O2-induced ROS by maintaining mitochondrial homeostasis and cellular tight junction in HaCaT keratinocytes. Antioxidants 12:902. https://doi.org/10.3390/ANTIOX12040902
Kwak HJ, Yang D, Hwang Y et al (2017) Baicalein protects rat insulinoma INS-1 cells from palmitate-induced lipotoxicity by inducing HO-1. PLoS One 12. https://doi.org/10.1371/journal.pone.0176432
Lee JH, Li YC, Ip SW et al (2008) The role of Ca2+ in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria- and caspase-3-dependent pathway. Anticancer Res 28:1701–1711
Lee K, Jeon Y, Byun Y, et al (2021) Pharmaceutical composition for preventing or treating allergic diseases such as asthma or atopy including baicalein as active ingredient – Patent US-11166934-B2 – PubChem
Li Y, Su H, Pi X et al (2012) The stimulatory activities of baicalein and baicalin compounds derived from Scutellaria baicalensis on insulin secretion in vitro. Adv Mater Res 554–556:1673–1677. https://doi.org/10.4028/www.scientific.net/AMR.554-556.1673
Li M, Shi A, Pang H et al (2014) Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. J Ethnopharmacol 156:210–215. https://doi.org/10.1016/j.jep.2014.08.031
Li P, Hu J, Shi B, Tie J (2020) Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway. Biochem Biophys Res Commun 531:320–327. https://doi.org/10.1016/j.bbrc.2020.07.045
Li L, Gao H, Lou K et al (2021a) Safety, tolerability, and pharmacokinetics of oral baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled multiple-ascending-dose study. Clin Transl Sci 14:2017–2024. https://doi.org/10.1111/cts.13063
Li Y, Yang D, Jia Y et al (2021b) Research Note: Anti-inflammatory effects and antiviral activities of baicalein and chlorogenic acid against infectious bursal disease virus in embryonic eggs. Poult Sci 100:100987. https://doi.org/10.1016/j.psj.2021.01.010
Li J, Wang Y, Wu T et al (2022) Baicalein suppresses high glucose-induced inflammation and apoptosis in trophoblasts by targeting the miRNA-17-5p-Mfn1/2-NF-κB pathway. Placenta 121:126–136. https://doi.org/10.1016/j.placenta.2022.02.013
Lin CC, Shieh DE (1996) The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 24:31–36. https://doi.org/10.1142/S0192415X96000050
Liu T, Xu J, Wu Y et al (2020) Beneficial effects of baicalein on a model of allergic rhinitis. Acta Pharma 70:35–47. https://doi.org/10.2478/acph-2020-0009
Li-Weber M (2009) New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev 35:57–68. https://doi.org/10.1016/j.ctrv.2008.09.005
Luo YH, Zhang L, Wang MY et al (2021) Anti-cancer effects of baicalein on cervical carcinoma cells through down-regulation of the erk/p38/mapk pathway. J Biol Regul Homeost Agents 35:945–952. https://doi.org/10.23812/21-52-A
Ma D, Chen S, Wang H et al (2021) Baicalein induces apoptosis of pancreatic cancer cells by regulating the expression of miR-139-3p and miR-196b-5p. Front Oncol 11. https://doi.org/10.3389/fonc.2021.653061
Mo F, Ma J, Zhang P et al (2021) Solubility and thermodynamic properties of baicalein in water and ethanol mixtures from 283.15 to 328.15 K. Chem Eng Commun 208:183–196. https://doi.org/10.1080/00986445.2019.1700116
Moslehi M, Yazdanparast R (2013) Protective effects of flavonoid baicalein against menadione-induced damage in SK-N-MC cells. CellBio 02:35–44. https://doi.org/10.4236/cellbio.2013.22005
Motoo Y, Sawabu N (1994) Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines. Cancer Lett 86:91–95. https://doi.org/10.1016/0304-3835(94)90184-8
Myung K, Hong S, Saikat M, et al (2019) Synthetic-baicalein-derivative as chemotherapeutic agent – Patent WO-2021107730-A1 – PubChem
National Center for Biotechnology Information (2023) Baicalein
Oh MC, Piao MJ, Fernando PMDJ et al (2016) Baicalein protects human skin cells against ultraviolet B-induced oxidative stress. Biomol Ther 24:616–622. https://doi.org/10.4062/biomolther.2016.022
Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5. https://doi.org/10.1017/jns.2016.41
Pang H, Xue W, Shi A et al (2016) Multiple-ascending-dose pharmacokinetics and safety evaluation of baicalein chewable tablets in healthy Chinese volunteers. Clin Drug Investig 36:713–724. https://doi.org/10.1007/s40261-016-0418-7
Parajuli P, Joshee N, Rimando AM et al (2009) In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids. Planta Med 75:41–48. https://doi.org/10.1055/s-0028-1088364
Park YG, Choi J, Jung HK et al (2017) Baicalein inhibits tumor progression by inhibiting tumor cell growth and tumor angiogenesis. Oncol Rep 38:3011–3018. https://doi.org/10.3892/OR.2017.6007/HTML
Park C, Choi EO, Kim GY et al (2019) Protective effect of baicalein on oxidative stress-induced DNA damage and apoptosis in RT4-D6P2T schwann cells. Int J Med Sci 16:8–16. https://doi.org/10.7150/ijms.29692
Qiao D, Xing J, Duan Y et al (2022) The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7/FAK/AKT signaling pathway. Phytomedicine 100:154046. https://doi.org/10.1016/J.PHYMED.2022.154046
Ren M, Zhao Y, He Z et al (2021) Baicalein inhibits inflammatory response and promotes osteogenic activity in periodontal ligament cells challenged with lipopolysaccharides. BMC Complement Med Ther 21:1–11. https://doi.org/10.1186/s12906-021-03213-5
Sahu BD, Kumar JM, Sistla R (2015) Baicalein, a bioflavonoid, prevents cisplatin-induced acute kidney injury by up-regulating antioxidant defenses and down-regulating the MAPKs and NF-κB pathways. PLoS One 10:e0134139. https://doi.org/10.1371/journal.pone.0134139
Sannigrahi S, Mazumder UK, Mondal A et al (2010) Flavonoids of enhydra fluctuans exhibit anticancer activity against Ehrlich’s ascites carcinoma in mice. Nat Prod Commun 5:1239–1242. https://doi.org/10.1177/1934578x1000500818
Sarkar P, Nath K, Banu S (2019) Modulatory effect of baicalein on gene expression and activity of antioxidant enzymes in streptozotocin-nicotinamide induced diabetic rats. Brazilian J Pharm Sci 55:e18201. https://doi.org/10.1590/s2175-97902019000118201
Schubert D, Maher P, Chiruta C (2017) Neuroprotective polyphenol analogs – Patent US-9744164-B2 – PubChem
Shao ZH, Vanden Hoek TL, Qin Y et al (2002) Baicalein attenuates oxidant stress in cardiomyocytes. Am J Physiol Heart Circ Physiol 282:H999. https://doi.org/10.1152/ajpheart.00163.2001
Shaw S, Naegeli P, Etter J-D, Weidmann P (1995) Role of intracellular signalling pathways in hydrogen peroxide-induced injury to rat glomerular mesangial cells. Clin Exp Pharmacol Physiol 22:924–933. https://doi.org/10.1111/j.1440-1681.1995.tb02328.x
Song L, Chen X, Wang P et al (2018) Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway. Acta Biochim Biophys Sin Shanghai 50:586–596. https://doi.org/10.1093/abbs/gmy045
Song JW, Long JY, Xie L et al (2020) Applications, phytochemistry, pharmacological effects, pharmacokinetics, toxicity of Scutellaria baicalensis Georgi. And its probably potential therapeutic effects on COVID-19: A review. Chinese Med (United Kingdom) 15:1–26. https://doi.org/10.1186/s13020-020-00384-0
Susmitha GD, Miyazato K, Ogura K et al (2020) Anti-metastatic effects of baicalein by targeting STAT3 activity in breast cancer cells. Biol Pharm Bull 43:1899–1905. https://doi.org/10.1248/BPB.B20-00571
Taiming L, Xuehua J (2006) Investigation of the absorption mechanisms of baicalin and baicalein in rats. J Pharm Sci 95:1326–1333. https://doi.org/10.1002/JPS.20593
Trepat X, Chen Z, Jacobson K (2012) Cell migration. Compr Physiol 2:2369–2392. https://doi.org/10.1002/cphy.c110012
Tuan PA, Kim YS, Kim Y et al (2018) Molecular characterization of flavonoid biosynthetic genes and accumulation of baicalin, baicalein, and wogonin in plant and hairy root of Scutellaria lateriflora. Saudi J Biol Sci 25:1639–1647. https://doi.org/10.1016/j.sjbs.2016.08.011
Waisundara VY, Hsu A, Tan BKH, Huang D (2009) Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats. Diabetes Metab Res Rev 25:671–677. https://doi.org/10.1002/DMRR.1005
Wang J, Huang W, Chen S (2009) Methods of treating traumatic brain injury by administering baicalein preparation – Patent US-2011124721-A1 – PubChem
Wang Y, Han E, Xing Q et al (2015) Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells. Cancer Lett 358:170–179. https://doi.org/10.1016/j.canlet.2014.12.033
Wang X, Cai H, Chen Z et al (2021) Baicalein alleviates pyroptosis and inflammation in hyperlipidemic pancreatitis by inhibiting NLRP3/Caspase-1 pathway through the miR-192-5p/TXNIP axis. Int Immunopharmacol 101:108315. https://doi.org/10.1016/j.intimp.2021.108315
Wu H, Long X, Yuan F et al (2014) Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin. Acta Pharm Sin B 4:217–226. https://doi.org/10.1016/j.apsb.2014.03.002
Xiang Q, Wang J, Wang T, Zuo H (2021) Combination of baicalein and miR-106a-5p mimics significantly alleviates IL-1β-induced inflammatory injury in CHON-001 cells. Exp Ther Med 21:1–1. https://doi.org/10.3892/etm.2021.9776
Xiao J, Capanoglu E, Jassbi AR, Miron A (2016) Advance on the flavonoid C-glycosides and health benefits. Crit Rev Food Sci Nutr 56:S29–S45. https://doi.org/10.1080/10408398.2015.1067595
Xing J, Chen X, Zhong D (2005) Absorption and enterohepatic circulation of baicalin in rats. Life Sci 78:140–146. https://doi.org/10.1016/j.lfs.2005.04.072
Xu D, Chen Q, Liu Y, Wen X (2017) Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction. Oncotarget 8:105561–105573. https://doi.org/10.18632/oncotarget.22319
Yan JJ, Hua DG, Mei QX, Gao L (2020) Baicalein attenuates the neuroinflammation in LPS-activated BV-2 microglial cells through suppression of pro-inflammatory cytokines, COX2/NF-κB expressions and regulation of metabolic abnormality. Int Immunopharmacol 79. https://doi.org/10.1016/j.intimp.2019.106092
Yang X, Jiang J, Zhang C, Li Y (2019a) Baicalein restrains proliferation, migration, and invasion of human malignant melanoma cells by down-regulating colon cancer associated transcript-1. Brazilian J Med Biol Res 52. https://doi.org/10.1590/1414-431x20198934
Yang Z, Huang W, Zhang J et al (2019b) Baicalein improves glucose metabolism in insulin resistant HepG2 cells. Eur J Pharmacol 854:187–193. https://doi.org/10.1016/j.ejphar.2019.04.005
Yao LH, Jiang YM, Shi J et al (2004) Flavonoids in food and their health benefits. Plant Foods Hum Nutr 59:113–122. https://doi.org/10.1007/S11130-004-0049-7
Yao J, Liu T, Chen RJ et al (2020) Sphingosine-1-phosphate signal transducer and activator of transcription 3 signaling pathway contributes to baicalein-mediated inhibition of dextran sulfate sodium-induced experimental colitis in mice. Chin Med J 133:292–300. https://doi.org/10.1097/CM9.0000000000000627
Zhang BW, Li X, Sun WL et al (2017) Dietary flavonoids and acarbose synergistically inhibit α-glucosidase and lower postprandial blood glucose. J Agric Food Chem 65:8319–8330. https://doi.org/10.1021/acs.jafc.7b02531
Zhang J, Yang W, Zhou YB et al (2018) Baicalein inhibits osteosarcoma cell proliferation and invasion through the miR-183/Ezrin pathway. Mol Med Rep 18:1104–1112. https://doi.org/10.3892/mmr.2018.9036
Zhang M, Ye L, Cheng C et al (2021a) Dietary flavone baicalein combinate with genipin attenuates inflammation stimulated by lipopolysaccharide in RAW264.7 cells or pseudomonas aeruginosa in mice via regulating the expression and phosphorylation of AKT. Nutrients 13. https://doi.org/10.3390/nu13124462
Zhang X, Qin Y, Ruan W et al (2021b) Targeting inflammation-associated AMPK//Mfn-2/MAPKs signaling pathways by baicalein exerts anti-atherosclerotic action. Phyther Res 35:4442–4455. https://doi.org/10.1002/ptr.7149
Zhang FW, Yang PL, Shi CJ et al (2022) Baicalein mediates the anti-tumor activity in osteosarcoma through lncRNA-NEF driven Wnt/β-catenin signaling regulatory axis. J Orthop Transl 33:132–141. https://doi.org/10.1016/j.jot.2021.12.001
Zhao Q, Chen XY, Martin C (2016) Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plants. Sci Bull 61:1391–1398. https://doi.org/10.1007/s11434-016-1136-5
Acknowledgments
Lucian Hritcu was supported by a grant of the Ministry of Research, Innovation and Digitization, CNCS-UEFISCDI, project number PN-III-P4-PCE-2021-1692, within PNCDI III.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Hritcu, L., Edmond, M.P., Eldahshan, O.A. (2023). Baicalein: Advances on Resources, Biosynthesis Pathway, Bioavailability, Bioactivity, and Pharmacology. In: Xiao, J. (eds) Handbook of Dietary Flavonoids. Springer, Cham. https://doi.org/10.1007/978-3-030-94753-8_3-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-94753-8_3-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94753-8
Online ISBN: 978-3-030-94753-8
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences